← Leaderboards
Karl A Scheidt
Harvard University
$13,329,766
Attributed
$17,966,163
Total exposure
16
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.6M · FY2006–25$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$23,700,480 · 17
By mechanism
R01$10,525,357 · 7
P30$6,387,443 · 2
R25$2,645,893 · 2
R35$2,440,996 · 1
R21$1,257,897 · 3
S10$410,478 · 1
Top collaborators
- Michael A. Rogawski10 shared
- Barbara Stauch Slusher10 shared
- Stephen J. Kron8 shared
- Alfred L George5 shared
- Marcie A Glicksman5 shared
- Susan E Quaggin5 shared
- Shi-Yuan Cheng2 shared
- H. Daniel Lacorazza2 shared
Others in their field
Top investigators on “Biological”
- David Heimbrook · Leidos Biomedical Research, Inc.$731,505,112
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Lawrence Corey · Fred Hutchinson Cancer Center$543,202,300
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$480,487,534
- Tracy L Nolen · Research Triangle Institute$474,487,152
Research focus
BiologicalBaseLeadProgramsSmall MoleculeDesignFundingBiologyChemistryChemical SynthesisCellsStructureMedicineReactionNovel TherapeuticsSuccessInnovationMalignant NeoplasmsResearch PersonnelAnalogCollaborationsMolecularTranslatingNatural Products
Grant awards (71)
A Molecular Approach to Dissecting MEK-Mediated Phosphorylation in Pediatric Leukemia$652,805
R01 · FY2025 · CA · contact PI
PAIRS: Validating telomerase reverse transcriptase (TERT) as an intrinsic vulnerability toward sensitizing cancer to radiation$481,444
R01 · FY2025 · CA
New Cooperative Catalysis Concepts for Asymmetric Synthesis$465,511
R35 · FY2025 · GM · contact PI
A Molecular Approach to Dissecting MEK-Mediated Phosphorylation in Pediatric Leukemia$667,807
R01 · FY2024 · CA · contact PI
PAIRS: Validating telomerase reverse transcriptase (TERT) as an intrinsic vulnerability toward sensitizing cancer to radiation$437,187
R01 · FY2024 · CA
New Cooperative Catalysis Concepts for Asymmetric Synthesis$393,357
R35 · FY2024 · GM · contact PI
Bioinspired chemical probe approach targeting telomerase reverse transcriptase$366,747
R01 · FY2024 · CA · contact PI
Medicinal and Synthetic Chemistry Core Facility Shared Resource$42,226
P30 · FY2024 · CA · contact PI
PAIRS: Validating telomerase reverse transcriptase (TERT) as an intrinsic vulnerability toward sensitizing cancer to radiation$472,393
R01 · FY2023 · CA
New Cooperative Catalysis Concepts for Asymmetric Synthesis$393,357
R35 · FY2023 · GM · contact PI
Bioinspired chemical probe approach targeting telomerase reverse transcriptase$378,329
R01 · FY2023 · CA · contact PI
Targeting ATG4B to Treat Glioblastoma$192,478
R21 · FY2023 · NS · contact PI
Medicinal and Synthetic Chemistry Core Facility Shared Resource$42,226
P30 · FY2023 · CA · contact PI
Kidney Therapeutics: Translating Discoveries into Prevention, Treatment and Cures for Kidney Diseases$1,120,048
P30 · FY2022 · DK
New Cooperative Catalysis Concepts for Asymmetric Synthesis$393,357
R35 · FY2022 · GM · contact PI
Bioinspired chemical probe approach targeting telomerase reverse transcriptase$378,327
R01 · FY2022 · CA · contact PI
Targeting ATG4B to Treat Glioblastoma$230,449
R21 · FY2022 · NS · contact PI
Medicinal and Synthetic Chemistry Core Facility Shared Resource$108,502
P30 · FY2022 · CA · contact PI
Kidney Therapeutics: Translating Discoveries into Prevention, Treatment and Cures for Kidney Diseases$1,133,852
P30 · FY2021 · DK
New Cooperative Catalysis Concepts for Asymmetric Synthesis$392,246
R35 · FY2021 · GM · contact PI
Bioinspired chemical probe approach targeting telomerase reverse transcriptase$385,304
R01 · FY2021 · CA · contact PI
Training in Neurotherapuetics and Development for Academic Scientists$264,890
R25 · FY2021 · NS
Medicinal and Synthetic Chemistry Core Facility Shared Resource$108,502
P30 · FY2021 · CA · contact PI
New Cooperative Catalysis Concepts for Asymmetric Synthesis$89,083
R35 · FY2021 · GM · contact PI
Kidney Therapeutics: Translating Discoveries into Prevention, Treatment and Cures for Kidney Diseases$1,145,719
P30 · FY2020 · DK
A Synthesis Platform to Leverage the Neuroscience Potential of Yohimbine Alkaloids$418,284
R21 · FY2020 · NS · contact PI
Bioinspired chemical probe approach targeting telomerase reverse transcriptase$397,571
R01 · FY2020 · CA · contact PI
New Cooperative Catalysis Concepts for Asymmetric Synthesis$314,085
R35 · FY2020 · GM · contact PI
TRAINING IN NEUROTHERAPUETICS AND DEVELOPMENT FOR ACADEMIC SCIENTISTS$264,890
R25 · FY2020 · NS
Medicinal and Synthetic Chemistry Core Facility Shared Resource$108,502
P30 · FY2020 · CA · contact PI
Kidney Therapeutics: Translating Discoveries into Prevention, Treatment and Cures for Kidney Diseases$1,155,697
P30 · FY2019 · DK
New Acid Catalysis Concepts for Asymmetric Synthesis$305,270
R01 · FY2019 · GM · contact PI
TRAINING IN NEUROTHERAPUETICS AND DEVELOPMENT FOR ACADEMIC SCIENTISTS$265,032
R25 · FY2019 · NS
Exploring Mellpaladines as New Serotonin Receptor Antagonists$188,123
R21 · FY2019 · MH · contact PI
Medicinal and Synthetic Chemistry Core Facility Shared Resource$108,502
P30 · FY2019 · CA · contact PI
Kidney Therapeutics: Translating Discoveries into Prevention, Treatment and Cures for Kidney Diseases$1,179,001
P30 · FY2018 · DK
Carbene Catalysis Strategies for Organic Synthesis$356,904
R01 · FY2018 · GM · contact PI
TRAINING IN NEUROTHERAPUETICS AND DEVELOPMENT FOR ACADEMIC SCIENTISTS$267,733
R25 · FY2018 · NS
Exploring Mellpaladines as New Serotonin Receptor Antagonists$228,563
R21 · FY2018 · MH · contact PI
Medicinal and Synthetic Chemistry Core Facility Shared Resource$110,658
P30 · FY2018 · CA · contact PI
Medicinal and Synthetic Chemistry Core Facility Shared Resource$8,621
P30 · FY2018 · CA · contact PI
Medicinal and Synthetic Chemistry Core Facility Shared Resource$8,489
P30 · FY2018 · CA · contact PI
Medicinal and Synthetic Chemistry Core Facility Shared Resource$6,898
P30 · FY2018 · CA · contact PI
Carbene Catalysis Strategies for Organic Synthesis$356,904
R01 · FY2017 · GM · contact PI
Discovery of Selective MAP2K4 Inhibitors to Target Metastasis$346,802
R01 · FY2017 · CA · contact PI
TRAINING IN NEUROTHERAPUETICS AND DEVELOPMENT FOR ACADEMIC SCIENTISTS$268,551
R25 · FY2017 · NS
Supplement to Carbene Catalysis Strategies for Organic Synthesis$99,471
R01 · FY2017 · GM · contact PI
Carbene Catalysis Strategies for Organic Synthesis$356,904
R01 · FY2016 · GM · contact PI
Discovery of Selective MAP2K4 Inhibitors to Target Metastasis$346,802
R01 · FY2016 · CA · contact PI
Training in Neurotherapeutics Discovery and Development for Academic Scientists$261,858
R25 · FY2016 · NS
Carbene Catalysis Strategies for Organic Synthesis$363,026
R01 · FY2015 · GM · contact PI
Discovery of Selective MAP2K4 Inhibitors to Target Metastasis$346,802
R01 · FY2015 · CA · contact PI
Training in Neurotherapeutics Discovery and Development for Academic Scientists$262,693
R25 · FY2015 · NS
Carbene Catalysis Strategies for Organic Synthesis$280,961
R01 · FY2014 · GM · contact PI
Training in Neurotherapeutics Discovery and Development for Academic Scientists$263,345
R25 · FY2014 · NS
Carbene Catalysis Strategies for Organic Synthesis$271,882
R01 · FY2013 · GM · contact PI
Training in Neurotherapeutics Discovery and Development for Academic Scientists$257,513
R25 · FY2013 · NS
Carbene Catalysis Strategies for Organic Synthesis$306,798
R01 · FY2012 · GM · contact PI
Training in Neurotherapeutics Discovery and Development for Academic Scientists$269,388
R25 · FY2012 · NS
Carbene Catalysis Strategies for Organic Synthesis$54,089
R01 · FY2012 · GM · contact PI
Carbene Catalysis Strategies for Organic Synthesis$266,816
R01 · FY2011 · GM · contact PI
Synthesis of Anticancer Pyran Natural Products$275,174
R01 · FY2010 · CA · contact PI
New Polarity Reversal Strategies for Organic Synthesis$253,050
R01 · FY2010 · GM · contact PI
An Integrated Open-Access HT Preparative Chromatography System for Molecular Medi$410,478
S10 · FY2009 · RR · contact PI
New Polarity Reversal Strategies for Organic Synthesis$292,876
R01 · FY2009 · GM · contact PI
Synthesis of Anticancer Pyran Natural Products$275,633
R01 · FY2009 · CA · contact PI
New Polarity Reversal Strategies for Organic Synthesis$36,972
R01 · FY2009 · GM · contact PI
New Polarity Reversal Strategies for Organic Synthesis$238,396
R01 · FY2008 · GM · contact PI
New Polarity Reversal Strategies for Organic Synthesis$238,998
R01 · FY2007 · GM · contact PI
New Polarity Reversal Strategies for Organic Synthesis$236,913
R01 · FY2006 · GM · contact PI
CATALYTIC ENANTIOSELECIVE SYNTHESIS OF ALLYLAMINES$32,416
F32 · FY2000 · GM